Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Crowell & Moring and Faber Daeufer launch life sciences practice
Americas
The firm’s new practice unites Faber’s transactional and licensing abilities with Crowell’s regulatory and litigation services, bringing together 50 professionals and expanding into Boston.   3 June 2025
Honigman lands two leading litigators in Chicago office
Americas
The seasoned patent litigators join from Mayer Brown, bringing decades of high-stakes experience in pharma and biotech patent disputes, including work on Hatch-Waxman and biosimilar litigation.   2 June 2025
Weight-loss clinic hits back at Novo Nordisk’s Ozempic TM allegations
Americas
Novo Nordisk faces resistance from Connecticut clinic in Ozempic and Wegovy dispute | LIVation admits to referencing Novo Nordisk products in past marketing but it has since been removed | Clinic claims its compounded semaglutide use was lawful and clear to patients.   29 May 2025
Europe
UPC rejects jurisdictional challenges from Moderna | Court allows two linked infringement cases over mRNA tech to move forward in The Hague | Ruling finds commercial links between Moderna entities enough to justify its jurisdiction over non-UPC territories.   27 May 2025
Europe
AstraZeneca subsidiary Alexion suffers setback in bid to stop rivals launching biosimilars of blood disorder drug | Ruling concerns an error in original patent application | Decision follows UPC defeat for Alexion over eculizumab patent.   22 May 2025
Americas
Illumina claims Element’s AVITI sequencing platforms includes patented tech | Biotech firm alleges it infringes its MiSeq and MiniSeq system | Start-up founded by former Illumina employees.   19 May 2025
Pharma
Trademark activity surged across major markets in 2024 | Swiss pharma ranks among top foreign portfolios in US, UK and EU | Mainland China is largest filer worldwide despite dip in applications | Several major life sciences companies held strong US trademark portfolios.   15 May 2025
Americas
Court partially overturns PTAB decision favouring Broad Institute in the long-running gene-editing patent dispute | Case sent back to clarify invention conception | Third parties face "yet more delays" in a patent landscape that appears "constantly in flux".   13 May 2025
Americas
Counsel are using their unique position as the centre of science and law to deliver value far beyond traditional IP protection, finds Marisa Woutersen.   9 May 2025
Americas
Wilson Sonsini, Desmarais, and Wolf Greenfield were among the winners at the inaugural LSPN Awards USA 2025 in Boston, which celebrated excellence in life sciences IP across 20 categories.   8 May 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.